Virginie Adam

7PUBLICATIONS
57CO-AUTHORS
Health informatics and information systemsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 09, 2024
Further Optimizing Care of Patients With Operable Hormone Receptor-Sensitive Breast Cancer.

Alexandra Thomas, Erica L Mayer, Angela DeMichele

|Aug 23, 2023
DECRESCENDO: de-escalating chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancer.

Véronique Debien, Virginie Adam, Elisabeth Coart

|Apr 25, 2022
A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ PIK3CA-mutated breast cancer.

Jose Alejandro Pérez-Fidalgo, Carmen Criscitiello, Eva Carrasco

|Jul 24, 2021
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study.

Nicholas C Turner, Judith Balmaña, Coralie Poncet

Pageof 2